{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1093/NAR/GKAA924",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/masi",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web service",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3390"
        },
        {
          "@id": "edam:topic_2840"
        },
        {
          "@id": "edam:topic_0634"
        },
        {
          "@id": "edam:topic_3375"
        },
        {
          "@id": "edam:topic_3697"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1093/NAR/GKAA924"
        },
        "pubmed:33125077"
      ],
      "sc:description": "Microbiota-active substance interactions database.\nActive Substance Interaction database.\nTry Examples: Bifidobacterium adolescentis, Enterococcus faecalis, Acarbose, Caffeic acid, Oxaprozin, Obesity, Colorectal cancer.\n\nA centralized and standardized database to catalog Microbiota-Active Substance Interaction (MASI) will be very useful for related research fields, including microbiota-related precision medicine, pharmaceutical research, food and nutrition research, clinical pharmacy, health management studies.\n\nAccumulating evidence about the interaction between human microbiota and active substances, especially for those therapeutically-relevant substances such as clinical used drugs and traditional medicines/herbs, is deepenning our understanding in the role of \"our second genome\" in human health and diseases, and opens new avenue for managing/treating human healthy problems/diseases by manipulating microbiota-human interactions.",
      "sc:featureList": {
        "@id": "edam:operation_0544"
      },
      "sc:name": "MASI",
      "sc:url": "http://www.aiddlab.com/MASI"
    }
  ]
}